Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Prostatic Neoplasms 8Breast Neoplasms 8Hot Flashes 2Carcinoma, Intraductal, Noninfiltrating 2Breast Carcinoma In Situ 2Sarcopenia 1Pain 1Obesity 1Lung Neoplasms 1Head and Neck Neoplasms 1Chronic Disease 1Carcinoma, Non-Small-Cell Lung 1Adenocarcinoma, Bronchiolo-Alveolar 1Adenocarcinoma of Lung 1

Interventions

Carboplatin 15Radiotherapy 13Erlotinib Hydrochloride 11Bevacizumab 10Paclitaxel 9Pemetrexed 8Gemcitabine 8Docetaxel 7Cisplatin 6Gefitinib 4Vinorelbine 3pegfilgrastim 2Topotecan 2Sorafenib 2Irinotecan 2Chemotherapy, Adjuvant 2sargramostim 1romidepsin 1lentiviral minigene vaccine of COVID-19 coronavirus 1irofulven 1cositecan 1Watchful Waiting 1Video-Assisted Surgery 1Thalidomide 1Taxes 1Sunitinib 1Soybean Proteins 1Selenomethionine 1Radiotherapy, Intensity-Modulated 1Radiotherapy, Conformal 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Adenocarcinoma, Bronchiolo-Alveolar × Soybean Proteins × Clear all
NCT01958372 2020-11-23

Radiation Therapy, Chemotherapy, and Soy Isoflavones in Treating Patients With Stage IIIA-IIIB Non-Small Cell Lung Cancer

Barbara Ann Karmanos Cancer Institute

Phase 1 Completed
11 enrolled
Thoracic

Adenocarcinoma of Lung, Adenocarcinoma, Bronchiolo-Alveolar, Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon âš¡